Introduction
============

Type 2 diabetes (T2D) is a complicated and chronic metabolic disease characterized by insulin resistance and pancreatic ß-cell dysfunction ([@ref1]). Many individuals have an apparent genetic susceptibility to T2D. In recent years, many T2D susceptibility genes were identified ([@ref2]--[@ref13]) due to the completion of the HapMap project, an International collaborative effort to help researchers identify genes associated with human disease, as well as the wide use of genome-wide association studies (GWAS) and candidate gene association studies. However, the exact number and nature of genes involved in T2D, the underlying genetic models, and their interaction with environmental factors remain unclear. GWAS are commonly performed, and several studies searching for T2D susceptibility genes have been performed. Recently, a GWAS and meta-analysis identified several novel T2D susceptibility loci in populations from Starr County, Texas, and Mexico City ([@ref14]). Among these, six risk loci (rs2240727 in TOMM7, rs849230 in PARD3B, rs149228 in LOC729993, rs16862811 in EPHA4, rs3099797 in HNT, and rs649891 in PTPRD) were strongly associated with T2D attracted our attention. PTPRD, or protein tyrosine phosph-atase receptor type D, is located on chromosome 9p23-p24.3. The protein encoded by this gene is protein tyrosine phosphatase (PTPs), which are signaling molecules that regulate various cellular processes including cell growth, differentiation, mitosis, and oncogenic transformation. PTPRD is expressed widely in tissues including skeletal muscle and the pancreas, with the highest level of expression in the brain. The rs17584499 locus of the PTPRD gene is associated with T2D in individuals from Chinese Taiwan (*OR* = 1.57, *P* = 8.54 × 10^-10^) ([@ref15]). The rs649891 locus of the same gene is also associated with T2D (*OR* = 1.29, *P* = 1.69 × 10^-4^) ([@ref14]). In addition, a prospective cohort study ([@ref16]) performed on a Chinese Han population demonstrated that carriers of the TT genotype at the rs17584499 locus of the PTPRD gene were more likely to progress from non-diabetes to diabetes (relative risk (RR) = 8.82, *P* = 4 × 10^-5^). Therefore, the PTPRD genetic variant appears to be associated with the progression to diabetes in the Chinese Han population, most likely due to increased insulin resistance.

However, many of the observed associations between genetic variants and T2D have not been reported in Chinese minority groups. Because T2D susceptibility genes exhibit heterogeneity among races and nationalities, we can not simply extrapolate the above findings to other ethnic populations with different living environments and genetic backgrounds. One study ([@ref17]) reported that the prevalence of T2D is significantly lower in ethnic Dong individuals compared with the ethnic Han population in China; however the reason for this is unclear. Therefore, we performed this study to examine the associations between seven newly discovered diabetes-related genes, which were identified in Mexican-American populations predominantly, and T2D in Chinese Dong populations.

Materials and Methods
=====================

Subjects
--------

A case-controlled study was performed in ethnic Dong populations of Tongdao Dong Autonomous County in Hunan, China. This study included 272 subjects, with 136 T2D (43.4% males, with a mean ± *SD* age of 62.47 ± 9.41 years) and 136 healthy controls (39.7% males, aged 61.23 ± 11.20 years) matched for ethnicity, age, and gender. T2D was diagnosed using the world health organization (WHO) criteria ([@ref18]): fasting plasma glucose (FPG) ≥ 7.0 mmol/L, or 2-hour postprandial glucose (2hPG) ≥ 11.1 mmol/L. General overweight or obesity was defined as a body mass index (BMI) ≥ 24 or ≥ 28 kg/m^2^ respectively, which was modified for Chinese Han populations ([@ref19]). The inclusion criteria for controls was (i) ≥ 40 years of age, (ii) FPG \<6.1 mmol/L and 2-hour postprandial glucose (2hPG) \<7.8 mmol/L, (iii) no history of diabetes in first or second degree relatives. Patients with severe liver and kidney disease and pregnant females were excluded. Written informed consent was obtained from all participants before this study started. The study was conducted according to the principles of the Declaration of Helsinki, and was approved by the Research Ethics Committee of Central South University. Demographic and clinical data were collected from conducted interviews and physical examinations. Blood specimens were collected for genetic testing from clinically confirmed cases of T2D and the healthy controls.

All subjects underwent an oral glucose tolerance test (OGTT), 5 ml of the fasting and the 2-hour postprandial venous blood were extracted respectively, and the fasting venous blood was separated into two tubes: one tube was used for testing FPG, fasting insulin levels (FINS), total cholesterol(TC), trigalloyl glycerol(TG), high density lipoprotein cholesterol(HDL-C) and low density lipoprotein cholesterol(LDL-C), the second was a disodium ethylene diamine tetraacetic acid (EDTA) tube for genetic testing. FPG and 2hPG were measured using the plasma glucose oxidase method. The FINS was tested using the human insulin ELISA kit and the TC, TG, HDL-C, LDL-C were tested using the corresponding kits provided by the Dingguo bio-technology company in Beijing, China. Simultaneously, the homeostasis model assessment (HOMA) insulin resistance (HOMA-IR) and HOMA model B-cell function indices (HOMA-B) were calculated by the following formulae: HOMA-IR = FINS × FPG / 22.5, and HOMA-B = FlNS × 20/ (FPG -3.5).

DNA isolation
-------------

Genomic DNA was extracted from the mononu-clear cells of peripheral blood using an Easy Nucleic Acid Isolation SE Blood DNA Kit (Qiagen, Germany) according to the manufacturer's instructions. DNA was amplified using Multiple PCR-SNaPshot ([@ref20], [@ref21]), and the amplified genomic DNA products were genotyped using GeneMapper 4.1 (Applied Biosystems Co., Ltd., USA). All the gene amplification and genotyping technologies were performed by Center for Human Genetics Research, Shanghai Genesky Bio-Tech Co., Ltd.

Multiplex PCR amplification of genomic DNA
------------------------------------------

As showed in [Table 1](#T1){ref-type="table"}, a total of 7 pairs of PCR primers were designed to amplify seven 122-250 bp fragments each containing a specific locus, and seven extension primers adjacent to the single nucleotide polymorphism (SNP) loci were used for single base extension. PCR products were obtained from multiple PCR reactions using HotStarTaq (Qiagen), after purification using shrimp alkali enzyme (SAP; Promega) and exonuclease I (EXO I) (Epicentre). The PCR products then underwent an extension reaction using SNaPshot Multiplex kit (ABI), and the extension products were purified using Promega SAP in an ABI3130xl sampler. The SNP genotyping results were read using GeneMapper 4.1. PCR reactions were performed in 10 µL reaction volumes containing 1× HotStar Taq buffer, 3.0 mM Mg^2+^, 0.3 mM dNTP, 1 U HotStar Taq Polymerase (Qiagen), 1 µL sample DNA, and 1 µL multiplex PCR primers. PCR cycling conditions were as follows: 95 °C for 2 min; followed by 11 cycles of 94 °C for 20 s, 65 °C (-0.5 °C/cycle) for 40 s, and 72 °C for 90 s; 24 cycles of 94 °C for 20 s, 59 °C for 30 s, and 72 °C for 90 s; and 72 °C for 120 s. Samples were then cooled to 4 °C when reactions were complete. PCR products were purified using 5U SAP and 2U Exonuclease I in 15 µL PCR product, incubated at 37 °C for 1 h, and then inactivated at 75 °C for 15 min.

###### 

PCR primers used to analyze seven SNP loci

  SNP locus    Primer position                   Primer sequence               length   Tm
  ------------ --------------------------------- ----------------------------- -------- -------
  rs849230     Upstream                          CAGGCAGTCACTTCCCTGTTATTG      24bp     64.18
  Downstream   AAAATCTTTCTTCTTTCCTTACTCGCTCTC    30bp                          64.61    
  rs149228     Upstream                          GATGATTGACATTTTGCCAGAATCA     25bp     64.27
  Downstream   GAGCCCCCTTTCTGCCCTAACT            22bp                          66.00    
  rs16862811   Upstream                          GAAACAGTCTCCCACCCTCTTGTATTG   27bp     66.10
  Downstream   TTCAGTGAGCAGGTTCGCATTC            22bp                          64.87    
  rs3099797    Upstream                          AAATGCCCTCAGGTCAGGAACC        22bp     65.77
  Downstream   GGAAGTTTCAAGCTGTGGATGGAGA         25bp                          66.83    
  rs17584499   Upstream                          CCAGGCTTTCCTGGTCAGTAACAT      24bp     64.74
  Downstream   GCTGGGCCCAAGAAAAGACAAC            22bp                          66.26    
  rs649891     Upstream                          TTACGCGTGTGAGTATGCCTCTCT      24bp     64.43
  Downstream   TGACGGAGGTATTTGTTGTTGTATACATTT    30bp                          64.49    
  rs2240727    Upstream                          CACTGCAAAGGGAAACTGTAATCCATA   27bp     65.24
  Downstream   GGTAAAAATTAAGCCTTTTGGTACTTTCTCA   31bp                          64.54    

SNaPshot multiple single-base extension reaction and genotyping
---------------------------------------------------------------

The following extending primers were used:

rs849230SF: TTTTTTTTTTTTTTTTGTTTGGTAACTGTCTCCTCTGTTA, Tm: 60.46 °C; rs149228SR: ttTTTTTTTTTTTTTTTTTTTTTTTTTTCCATGGCCAA GTGCCTCA, Tm: 66.19 °C; rs16862811SR: ttTTTTTTTTTTTTTTTTTTTTCGCATTCTAGTACAGGGATTAAAAACTm: 60.59 °C; rs3099797SF: CTAATCTGCAGTACCTGTTTAAACCA, Tm: 60.01 °C; rs17584499SR: GGACCCAGGCCTCTCTCTG, Tm: 62.3 °C; rs649891 SF:TAATATTTTGATTTAGTCTCTTATATTTAAGATAGTC, Tm: 57.49 °C; rs2240727SR: TTTTTGCCTTTTGGTACTTTCTCAAAACAG, Tm: 61.60 °C.

Extending reactions were then performed in a 10-µL reaction volume consisting of 5 µL SNaPshot Multiplex Kit (ABI), 2 µL purified multiplex PCR products, 1 µL extension primer mixture, and 2 µL of ultrapure water. Reactions were then cycled at 96 °C for 1 min, followed by 28 cycles of 96 °C for 10 s, 52 °C for 5 s, and 60 °C for 30 s, and then held at 4 °C. Extension products were then purified by the addition of 1U SAP enzyme to 10 µL extended products, incubation at 37 °C for 1 h, and inactivation at 75 °C for 15 min.

The extended products were then genotyped using an ABI3130 XL sequencer. After purification, 0.5 µL of the extended products were mixed with 0.5 µL of Liz120 size standard, 9 µL of Hi-Di, and denatured at 95°C for 5 min. The products were then added to the ABI3130XL sequencing instrument. The raw data collected from the ABI3130XL sequencing instrument were analyzed using GeneMapper 4.1. The results of SNaPshot genotyping are shown in [Fig. 1](#F1){ref-type="fig"}.

![The waveform and genotypes of seven polymorphic loci/Note: Fluorescently labeled extended products: G peak = blue; A peak = green; T peak = red; C peak = black](IJPH-43-1345-g001){#F1}

Quality control criteria that SNPs met qualify for further analysis included: a genotyping success rate \> 98.0%, a genotype concordance rate \> 99%, a call minor allele frequency \> 0.05 and no deviation of Hardy-Weinberg equilibrium (HWE) in cases and controls (all *P* \> 0.05) ([@ref22]).

Statistical analysis
--------------------

We tested the genotype distributions of the seven SNPs described above for HWE using χ^2^ -test implemented in Haploview version 4.2. ([@ref23]) The differences in continuously distributed variables were assessed using the Student's *t*-test and oneway analysis of variance (ANOVA), and categorical variables between the study groups were compared using chi-squared tests. Independent odds ratio (OR) and its 95% confidence interval (CI) were estimated using unconditional binary logistic regression as a measure of the association between genotype and risk of T2D. We performed power calculations using QUANTO software version 1.2.4, and corrected for multiple testing using Bonferroni correction to control type I error. Statistical analyses were performed using the SPSS software version 17.0 (SPSS, Chicago, IL, USA); *P* values \<0.05 were considered statistically significant.

Results
=======

The basic characteristics of the study population
-------------------------------------------------

A total of 272 (136 T2D patients and 136 health controls) ethnic Dong subjects were included in the final analyses. There were no differences in gender (59 and 54 males in the patient and healthy control groups, respectively) and age (mean ± SD of 62.47 ± 9.41 and 61.23 ± 11.20 years, respectively) between the study groups (*P* \> 0.05).

The compared results of the basic characteristics between patients and controls are shown in [Table 2](#T2){ref-type="table"}. The levels of BMI, FPG, 2hPG, HOMA-IR and TG were significantly higher in patients than in controls (all *P* \< 0.01), whereas HOMA-B and HDL-C were lower in patients than in controls (all *P* \< 0.05). There were no significant differences between patients and controls in age, sex, FINS, TC and LDL-C.

###### 

Comparison of the basic characteristics of the study populations

  Variable        Patients (n =136)   Controls (n =136)   Statistics   *P* value
  --------------- ------------------- ------------------- ------------ -----------
  Age(y)          62.47±9.41          61.23±11.20         0.99         0.323
  Sex(M/F)        59/77               54/82               0.538        0.623
  BMI             24.73±3.47          22.32±3.00          6.13         0.000\*\*
  FPG (mmol/L)    9.59±2.78           5.91±0.39           15.28        0.000\*\*
  2hPG (mmol/L)   12.85±4.05          6.83±1.29           16.25        0.000\*\*
  FINS (uIU/ml)   14.17±5.37          15.52±6.05          1.95         0.052
  HOMA-IR         6.02±2.87           4.08±1.63           6.85         0.000\*\*
  HOMA-B          53.88±30.18         119.41±37.15        15.97        0.000\*\*
  TC(mmol/L)      6.16±1.36           6.06±1.18           0.670        0.503
  TG(mmol/L)      2.56±1.55           1.76±1.05           4.939        0.000\*\*
  HDL-C(mmol/L)   0.92±0.22           0.98±0.25           -2.155       0.032\*
  LDL-C(mmol/L)   1.50±0.39           1.45±0.38           1.056        0.292

Note: Values are expressed as means ± SD. \*

P

value \< 0.05, \*\*

P

value \< 0.01 ; All

P

values are noted for the comparison with the control group; Comparisons were performed by Student t test and Chi-square test. BMI: Body mass index, FPG: Fasting plasma glucose, 2hPG: 2hour postprandial glucose, FINS: Fasting insulin level, HOMA-IR: HOMA model insulin resistance index, HOMA-B: HOMA model ß-cell function index, total cholesterol(TC) , trigalloyl glycerol(TG), high density lipoprotein cholesterol(HDL-C) and low density lipoprotein cho-lesterol(LDL-C).

Allele and genotype distribution
--------------------------------

All of the seven SNPs examined in the present study were in HWE, and all the minimum allele frequencies (MAF) were \> 1%, consistent with the principles of population genetics. The response rate of each polymorphic locus was \> 99.0%. The statistical powers of the seven genetic loci ranged from 85 to 94%, which was sufficient to detect the associations between T2D and the loci.

As shown in [Table 3](#T3){ref-type="table"}, the frequencies of the risk T allele and the CT and TT genotypes at rs2240727 of TOMM7 were significantly higher in patients than in controls; a significant association between T2D and rs2240727 was observed (for the T al- lele: OR = 1.65, 95% CI 1.17-2.32, *P* = 0.004; for the CT genotype: OR = 2.64, 95%\>*CI* 1.28-5.45, *P*=0.007, for the TT genotype: *OR* = 3.42, 95% CI 1.58-7.41, *P* = 0.001). After Bonferroni correcting for multiple testing, the association remained significant (*P* \< 0.05). We also performed unconditional binary logistic regression to assess the associations between rs2240727 and risk of T2D. The results suggested that, after adjusting for the confounders of age, gender, and BMI, the associations remained significant (*P* \< 0.05, [Table 4](#T4){ref-type="table"}). However, rs849230 of PARD3B, rs149228 of LOC729993, rs16862811 of EPHA4, rs3099797 of HNT, and rs17584499 and rs649891 of PTPRD showed no significant differences between groups. Therefore, these genetic loci were not associated with the risk of T2D in this population (all *P \>* 0.05).

###### 

Genetic association analysis of seven polymorphic loci with type 2 diabetes

               Chr.   Position (bp)   Candidate Genes   Risk allele   Allele and genotype   Patients *n* (%)   Controls *n*(%)   *OR* (95% *CI)* ^a^   *χ^2^*   *P~b~* value   *P~c~* value
  ------------ ------ --------------- ----------------- ------------- --------------------- ------------------ ----------------- --------------------- -------- -------------- --------------
  rs2240727    7      22819037        TOMM7             T             C                     99 (36.40)         132 (48.53)                                                     
                                                                      T                     173 (63.60)        140 (51.47)       1.65 (1.17-2.32)      8.194    0.004          0.028
                                                                      CC                    13 (9.56)          32 (24.26)                                                      
                                                                      CT                    73 (53.68)         68 (50.00)        2.64 (1.28-5.45)      7.186    0.007          0.049
                                                                      TT                    50 (36.76)         36(25.74)         3.42 (1.58-7.41)      10.125   0.001          0.007
  rs849230     2      205969274       PARD3B            A             G                     5 (1.84)           11 (4.04)                                                       
                                                                      A                     267 (98.16)        261(95.96)        2.25 (0.77-6.57)      2.374    0.123          
                                                                      GA                    5 (3.68)           11 (8.09)                                                       
                                                                      AA                    131 (96.32)        125 (91.91)       2.31 (0.78-6.82)      2.391    0.122          
  rs149228     16     13211975        LOC729993         C             A                     178 (65.44)        170 (62.50)                                                     
                                                                      C                     94 (34.56)         102 (37.50)       0.88 (0.62-1.25)      0.510    0.475          
                                                                      AA                    59 (43.38)         50 (36.76)                                                      
                                                                      CA                    60 (44.12)         70 (51.47)        0.73 (0.44-1.21)      1.508    0.219          
                                                                      CC                    17 (12.50)         16 (11.77)        0.90 (0.41-1.96)      0.070    0.792          
  rs16862811   2      222109330       EPHA4             G             T                     37 (13.60)         28 (10.29)                                                      
                                                                      G                     235 (86.40)        244 (89.71)       0.73 (0.43-1.23)      1.415    0.234          
                                                                      TG                    7 (5.15)           8(5.88)                                                         
                                                                      GT                    30 (22.06)         20(14.71)         1.64 (0.87-3.07)      0.837    0.360          
                                                                      GG                    99 (72.79)         108 (79.41)       0.96 (0.33-2.73)      0.008    0.931          
  rs3099797    11     131626596       HNT               C             T                     18 (6.62)          17 (6.25)                                                       
                                                                      C                     254 (93.38)        255 (93.75)       0.94 (0.47-1.87)      0.031    0.861          
                                                                      TT                    1 (0.74)           1 (0.74)                                                        
                                                                      CT                    16 (11.76)         15 (11.03)        1.08 (0.51-2.27)               1.000          
                                                                      CC                    119(87.50)         120 (88.23)       1.01 (0.06-16.31)     0.000    1.000          
  rs17584499   9                      PTPRD             T             C                     242 (88.97)        232 (85.29)                                                     
                                                                      T                     30 (11.03)         40 (14.71)        0.72 (0.43-1.19)      1.640    0.200          
                                                                      CC                    107 (78.68)        98 (72.06)                                                      
                                                                      CT                    28 (20.58)         36 (26.47)        0.71 (0.41-1.25)      1.391    0.238          
                                                                      TT                    1 (0.74)           2 (1.47)          0.46 (0.04-5.13)      0.005    0.946          
  rs649891     9      10420602        PTPRD             C             T                     60 (22.06)         69 (25.37)                                                      
                                                                      C                     212 (77.94)        203 (74.63)       1.20 (0.81-1.78)      0.823    0.364          
                                                                      TT                    8 (5.88)           7 (5.15)                                                        
                                                                      CT                    44 (32.35)         55 (40.44)        0.71 (0.43-1.17)      0.415    0.519          
                                                                      CC                    84 (61.77)         74 (54.41)        1.01(0.35-2.91)       0.000    0.990          

Notes: Chr chromosome, bp base-pair, OR odds ratio, CI confidence interval/

a

Odds ratios were calculated using the unconditional binary logistic regression to measure the ORs./

χ

2

values and

P

b

values were calculated using the Pearson chi-square test, compared with the first genotype./

Pc

was adjusted

P

value by Bonferroni correction

###### 

Multivariate Binary logistic regression analysis of diabetic risk factors

  Mode                       βe       SE.     Wald- *~χ~2*   df   Sig.    OR (95% CI)
  -------------------------- -------- ------- -------------- ---- ------- ------------------
  Constant                   -1.752   0.409   18.393         1    0.000   0.17
  Sex                        0.183    0.267   0.488          1    0.485   1.21(0.71-2.03)
  Age: \>60 years            0.448    0.263   2.894          1    0.089   1.57(0.93-2.62)
  BMI: overweight or obese   1.335    0.271   24.246         1    0.000   3.80(2.23-6.46)
  rs2240727: CT              1.056    0.390   7.315          1    0.007   2.87 (1.34-6.18)
       TT                    1.338    0.417   10.270         1    0.001   3.81(1.68-8.64)

Note: BMI Body mass index.

The association between the genotypes of rs2240727and the biochemical indicators
--------------------------------------------------------------------------------

We also performed one-way analysis of variance (ANOVA) to examine the association between FPG, 2hPG, FINS, HOMA-IR, HOMA-B, TC, TG, HDL-C, LDL-C and the genotypes of rs2240727 in the controls and the patients respectively, the results were shown in [Table 5](#T5){ref-type="table"} and [Table 6](#T6){ref-type="table"}. As shown in [Table 5](#T5){ref-type="table"}, there were significantly statistical difference in levels of FPG and HOMA-B among genotypes of rs2240727 in controls. The levels of FPG were significantly higher in CT and TT genotypes than in CC genotype, whereas the levels of HOMA-B were significantly lower in CT and TT genotypes than in CC genotype (all *P*\<0.05).

As shown in [Table 6](#T6){ref-type="table"}, there were significantly statistical difference in levels of FPG among genotypes of rs2240727 in the patients; the levels of FPG were significantly higher in CT and TT genotypes than in CC genotype, whereas there were no association between genotypes of rs2240727 and the other biochemical indicators.

###### 

Association analysis between the genotypes of rs2240727 and the biochemical indicators in the controls (mean ± SD)

  Variable        rs2240727      *F* value      *P* value               
  --------------- -------------- -------------- -------------- -------- -----------
  FPG (mmol/L)    5.53±0.28      5.78±0.33      5.94±0.26      16.581   0.000\*\*
  2hPG (mmol/L)   7.08±1.46      6.74±1.29      6.75±1.10      0.719    0.490
  INS (uIU/ml)    14.71±5.17     13.68±3.89     14.47±3.79     0.824    0.441
  HOMA-IR         3.62±1.28      3.51±1.02      3.82±1.01      0.967    0.383
  HOMA-B          147.49±56.11   122.93±40.38   120.01±34.93   4.317    0.015\*
  TC(mmol/L)      5.98±1.48      6.10±1.19      6.04±0.88      0.110    0.896
  TG(mmol/L)      1.79±0.97      1.74±1.03      1.78±1.17      0.023    0.977
  HDL-C(mmol/L)   1.00±0.28      0.95±0.24      1.01±0.24      1.016    0.365
  LDL-C(mmol/L)   1.53±0.42      1.41±0.40      1.46±0.29      1.183    0.310

NOTE: Comparisons were performed by the one way ANOVA. \*

P

value \< 0.05, \*\*

P

value \< 0.01.

###### 

Association analysis between the genotypes of rs2240727 and the biochemical indicators in the patients (mean ± SD)

  Variable        rs2240727     *F* value     *P* value             
  --------------- ------------- ------------- ------------- ------- ---------
  FPG (mmol/L)    8.22±0.90     8.64±0.92     9.38±2.67     3.500   0.033\*
  2hPG (mmol/L)   12.43±3.55    13.38±4.26    12.19±3.82    1.353   0.262
  INS (uIU/ml)    14.51±5.48    14.38±5.26    13.77±5.58    0.216   0.806
  HOMA-IR         5.23±1.75     5.49±1.96     5.56±2.48     0.286   0.751
  HOMA-B          66.73±43.90   58.33±26.05   54.78±29.55   0.876   0.419
  TC(mmol/L)      6.22±1.49     6.08±1.38     6.26±1.33     0.261   0.771
  TG(mmol/L)      2.40±1.31     2.62±1.60     2.50±1.55     0.150   0.861
  HDL-C(mmol/L)   0.93±0.17     0.90±0.21     0.94±0.23     0.525   0.593
  LDL-C(mmol/L)   1.51±0.44     1.54±0.43     1.45±0.31     0.884   0.461

NOTE: Comparisons were performed by the one way ANOVA. \*

P

value \< 0.05.

Discussion
==========

Type 2 diabetes is a complex polygenic disease. Recent increased economic development, improved living standards, and social demographic aging have caused the incidence of T2D to increase annually in both developed and developing countries. An epidemiological survey in 2003 demonstrated that there were nearly 200 million patients with diabetes worldwide, and this figure was estimated to exceed 300 million by 2025. Yang et al. ([@ref24]) reported that the age-standardized prevalence of diabetes is 9.7% in adults \>20 years old in 14 provinces and autonomous regions of China. The aim of this study was to assess the associations of seven novel genetic variants identified in a recent GWAS ([@ref14]) in Mexican American populations, and the gene expression study (1516) in a Chinese population.

The results of this study demonstrated that there were significant differences between the patients and the healthy controls in terms of BMI, FPG, 2hPG, HOMA-IR, HOMA-B, TG and HDL-C (all *P* \< 0.05). These data suggest that BMI, HOMA-IR, HOMA-B, TG and HDL-C might be environmental risk factors for T2D in Chinese Dong individuals, consistent with previous studies ([@ref25]--[@ref27]). Because these biochemical indicators were measured after disease onset, it was difficult to establish a causal relationship. Therefore, this should be assessed in a prospective study.

There are little studies have suggested roles for PARD3B, LOC729993, EPHA4, HNT, PTPRD, TOMM7, or intergenic regions in T2D. PARD3B is a homolog of a *C. elegans* cell polarity determinant that localizes to tight junctions in human epithelial cells. The cell polarity protein PAR3, conserved from nematodes to vertebrates, forms a complex with PAR6 and atypical protein kinase C (aPKC) at the tight junctions of mammalian epithelial cells. Previously, we cloned the human cDNA for a novel PAR3 homologue, designated PAR3beta, whose mRNA is present in a variety of tissues, but is expressed most abundantly in adult and fetal kidneys ([@ref28]). PARD3B is a large gene comprised of 23 exons located on chromosome 2, which encodes a 1205 amino acid protein from a gene 1.07 Mbp in length. Exon 20 can be alternately spliced, resulting in three potential variants. However, the functional significance of these different isoforms remains unclear, although they may have different expression patterns ([@ref29]). A previous study ([@ref14]) demonstrated that the rs849230 locus was associated with T2DM (OR = 1.83, 95% *CI*: 1.57-2.10).

TOMM7 gene is located on chromosome 7p15.3, and is also known as a homologene of the translocate mitochondrial outer membrane 7. This gene encodes a subunit of a mitochondrial outer membrane transporter that regulates components and the stability of transportation complex. A GWAS study ([@ref14]) reported that rs2240727 of the TOMM7 gene was associated with T2DM (OR = 1.37, 95% CI: 1.24-1.50).

Our study only replicated the associations between T2D and rs2240727 at TOMM7 (*P* = 0.005), the frequencies of T allele, CT and TT genotypes of rs2240727 were significantly higher in patients with T2D compared with healthy controls. These associations remained significant after adjusting the confounders of age, gender, and BMI. These findings suggest that TOMM7 is the diabetes gene which is independent of ethnic background, age, gender, and BMI. Moreover the OR (1.65, 95%CI: 1.17-2.32) of rs2240727 in TOMM7 in our study was slightly higher than that identified in previous European populations (OR = 1.37, 95% CI: 1.24-1.50), which suggests some potential ethnic and regional differences between this and the current study. This suggests that rs2240727 confers a higher risk of T2D in Chinese Dong populations than in Mexican-American populations. In addition, after correcting for multiple testing, the association between T2D and rs2240727 remained significant (*P* \< 0.05).

This study did not find any correlation between the rs849230, rs149228, rs16862811, rs3099797, rs17584499, and rs649891 loci with T2D in Chinese Dong individuals, which differs from the GWAS study ([@ref14]). This could be due to ethnic differences, and should be confirmed in further studies in different ethnic populations.

We also sought to determine whether there were any associations between rs2240727 and the biochemical indicators in controls and patients. We found that there were associations between FPG, HOMA-B and the genotypes of rs2240727 in controls, the levels of FPG were significantly higher in CT and TT genotypes than in CC genotype, whereas the levels of HOMA-B were significantly lower in CT and TT genotypes than in CC genotype (all *P* \< 0.05). We also found association between FPG and the genotypes of rs2240727 in patients. These findings suggested that rs2240727 of TOMM7 gene may induce the risk of T2D by affecting the level of FPG in Chinese Dong populations, but the really mechanism is not clearly. Therefore, further studies are needed to explore the pathogenesis of T2D and this gene.

Conclusion
==========

Our results present new evidence for the association between T2D and rs2240727 in TOMM7 gene in Chinese Dong populations, but further genetic and functional studies are needed to elucidate the biological processes underlying the association between T2D and rs2240727.
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